619 related articles for article (PubMed ID: 22314603)
1. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
Chapman K; Seldon M; Richards R
Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
[TBL] [Abstract][Full Text] [Related]
2. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases.
Franchini M; Montagnana M; Targher G; Lippi G
Semin Thromb Hemost; 2007 Nov; 33(8):787-97. PubMed ID: 18175284
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.
Schwameis M; Schörgenhofer C; Assinger A; Steiner MM; Jilma B
Thromb Haemost; 2015 Apr; 113(4):708-18. PubMed ID: 25503977
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
7. Methodologies and clinical utility of ADAMTS-13 activity testing.
Just S
Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
9. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?
Desch K; Motto D
J Am Soc Nephrol; 2007 Sep; 18(9):2457-60. PubMed ID: 17687074
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
Zhou Z; Nguyen TC; Guchhait P; Dong JF
Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
[TBL] [Abstract][Full Text] [Related]
11. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms in thrombotic thrombocytopenic purpura.
Tsai HM
Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
[TBL] [Abstract][Full Text] [Related]
14. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathies: multimers, metalloprotease, and beyond.
Moake J
Clin Transl Sci; 2009 Oct; 2(5):366-73. PubMed ID: 20443921
[TBL] [Abstract][Full Text] [Related]
16. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga JA; Alberio L
J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
[TBL] [Abstract][Full Text] [Related]
18. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
20. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
